A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

Journal of Neuro-Oncology

Volumn 124, Issue 2, 2015, Pages 299-305

  Streiff, Michael B ^a,b   Ye, Xiaobu ^a,c   Kickler, Thomas S ^a   Desideri, Serena ^c   Jani, Jayesh ^d   Fisher, Joy ^c   Grossman, Stuart A ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cancer; Factor VIII; Glioblastoma; Glioma; Risk factors; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 8; D DIMER;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; BLOOD GROUP ABO SYSTEM; CANCER GRADING; CANCER SURGERY; DISEASE ASSOCIATION; FATALITY; FEMALE; GLIOBLASTOMA; GLIOMA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; OUTPATIENT CARE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; TUMOR BIOPSY; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84942503320     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1840-z     Document Type: Article

References (33)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815
2. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715–722. doi:10.1001/jama.293.6.715
3. Wun T, White RH (2009) Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Investig 27(Suppl 1):63–74. doi:10.1080/07357900802656681
4. Brandes AA, Scelzi E, Salmistraro G, Ermani M, Carollo C, Berti F, Zampieri P, Baiocchi C, Fiorentino MV (1997) Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 33:1592–1596
5. Cheruku R, Tapazoglou E, Ensley J, Kish JA, Cummings GD, Al-Sarraf M (1991) The incidence and significance of thromboembolic complications in patients with high-grade gliomas. Cancer 68:2621–2624
6. Dhami MS, Bona RD, Calogero JA, Hellman RM (1993) Venous thromboembolism and high grade gliomas. Thromb Haemost 70:393–396
7. Quevedo JF, Buckner JC, Schmidt JL, Dinapoli RP, O’Fallon JR (1994) Thromboembolism in patients with high-grade glioma. Mayo Clin Proc 69:329–332
8. Ruff RL, Posner JB (1983) Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 13:334–336. doi:10.1002/ana.410130320
9. Semrad TJ, O’Donnell R, Wun T, Chew H, Harvey D, Zhou H, White RH (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106:601–608
10. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F et al (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484–3488. doi:10.1182/blood-2002-01-0108
11. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632–634. doi:10.1111/j.1538-7836.2007.02374.x
12. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH (2006) Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24:484–490. doi:10.1200/JCO.2005.03.8877
13. Trujillo-Santos J, Herrera S, Page MA, Soto MJ, Raventos A, Sanchez R, Monreal M, RIETE Investigators (2006) Predicting adverse outcome in outpatients with acute deep vein thrombosis. Findings from the RIETE Registry. J Vasc Surg 44:789–793. doi:10.1016/j.jvs.2006.06.032
14. Perry JR, Julian JA, Laperriere NJ, Geerts W, Agnelli G, Rogers LR, Malkin MG, Sawaya R, Baker R, Falanga A et al (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost 8:1959–1965. doi:10.1111/j.1538-7836.2010.03973.x
15. Perry SL, Bohlin C, Reardon DA, Desjardins A, Friedman AH, Friedman HS, Vredenburgh JJ (2009) Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients. J Neurooncol 95:129–134. doi:10.1007/s11060-009-9911-7
16. Robins HI, O’Neill A, Gilbert M, Olsen M, Sapiente R, Berkey B, Mehta M (2008) Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial. Cancer Chemother Pharmacol 62:227–233. doi:10.1007/s00280-007-0596-3
17. Kayser-Gatchalian MC, Kayser K (1975) Thrombosis and intracranial tumors. J Neurol 209:217–224
18. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H (1992) Postoperative venous thromboembolism and brain tumors: part I. Clinical profile. J Neurooncol 14:119–125
19. Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, Pabinger I, Marosi C (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol 9:89–95. doi:10.1215/15228517-2006-035
20. Valladares JB, Hankinson J (1980) Incidence of lower extremity deep vein thrombosis in neurosurgical patients. Neurosurgery 6:138–141
21. Sawaya R, Glas-Greenwalt P (1992) Postoperative venous thromboembolism and brain tumors: part II. Hemostatic profile. J Neurooncol 14:127–134
22. Sawaya R, Highsmith RF (1992) Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile. J Neurooncol 14:113–118
23. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG (2004) ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 100:1717–1723. doi:10.1002/cncr.20150
24. Thaler J, Ay C, Kaider A, Reitter EM, Haselbock J, Mannhalter C, Zielinski C, Marosi C, Pabinger I (2014) Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. Neuro Oncol 16:1645–1651. doi:10.1093/neuonc/nou106
25. Prell J, Rachinger J, Smaczny R, Taute BM, Rampp S, Illert J, Koman G, Marquart C, Rachinger A, Simmermacher S et al (2013) D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy. J Neurosurg 119:1340–1346. doi:10.3171/2013.5.JNS13151
26. Sartori M, Favaretto E, Cini M, Legnani C, Palareti G, Cosmi B (2014) D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome. Thromb Res 134:320–325. doi:10.1016/j.thromres.2014.05.043
27. Bertina RM (2003) Elevated clotting factor levels and venous thrombosis. Pathophysiol Haemost Thromb 33:395–400. doi:10.1159/000083835
28. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155
29. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343:457–462
30. Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, Zielinski C, Pabinger I (2009) High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol 29:2176–2181. doi:10.1161/ATVBAHA.109.190827
31. Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342:d813. doi:10.1136/bmj.d813
32. Roach RE, Lijfering WM, Rosendaal FR, Cannegieter SC, le Cessie S (2014) Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation 129:51–56. doi:10.1161/CIRCULATIONAHA.113.004768
33. Brotman DJ, Girod JP, Posch A, Jani JT, Patel JV, Gupta M, Lip GY, Reddy S, Kickler TS (2006) Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 118:247–252. doi:10.1016/j.thromres.2005.06.006